WHITEHAWK THERAPEUTICS, INC.: 10-Q filed 2014-08-14

Name: WHITEHAWK THERAPEUTICS, INC.: 10-Q filed 2014-08-14
Creator: WHITEHAWK THERAPEUTICS, INC.

What WHITEHAWK THERAPEUTICS, INC. reported in its quarterly report filed 2014-08-14 (fiscal Q2 2014): 16 published measures, 48 facts as tagged in accession 0001213900-14-005791.

This filing

Form: 10-Q (quarterly report)
Filed: 2014-08-14
Fiscal period: fiscal Q2 2014
Accession: 0001213900-14-005791 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All WHITEHAWK THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2014-06-30	4,568	USD
At 2013-12-31	8,783	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2014-06-30	-136,960	USD
At 2013-12-31	-124,242	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2014-06-30	4,568	USD
At 2013-12-31	6,283	USD
At 2013-06-30	18,420	USD
At 2013-03-31	2,706	USD
At 2012-12-31	4,607	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	-6,952	USD	91
2014-01-01 to 2014-06-30	-12,718	USD	181
2007-11-16 to 2014-06-30	-186,960	USD	2419
2013-04-01 to 2013-06-30	-6,749	USD	91
2013-01-01 to 2013-06-30	-12,812	USD	181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2014-01-01 to 2014-06-30	-1,715	USD	181
2007-11-16 to 2014-06-30	-155,432	USD	2419
2013-01-01 to 2013-06-30	-11,187	USD	181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2007-11-16 to 2014-06-30	160,000	USD	2419
2013-01-01 to 2013-06-30	25,000	USD	181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	-5,307	USD	91
2014-01-01 to 2014-06-30	-9,445	USD	181
2007-11-16 to 2014-06-30	-166,512	USD	2419
2013-04-01 to 2013-06-30	-5,456	USD	91
2013-01-01 to 2013-06-30	-10,262	USD	181

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	1,645	USD	91
2014-01-01 to 2014-06-30	3,273	USD	181
2007-11-16 to 2014-06-30	20,448	USD	2419
2013-04-01 to 2013-06-30	1,293	USD	91
2013-01-01 to 2013-06-30	2,550	USD	181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2014-06-30	141,528	USD
At 2013-12-31	133,025	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2014-06-30	8,155	USD
At 2013-12-31	350	USD

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2014-06-30	5,000,000	shares
At 2013-12-31	5,000,000	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2014-06-30	49,500	USD
At 2013-12-31	49,500	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2014-06-30	2,925	USD
At 2013-12-31	5,500	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	5,307	USD	91
2014-01-01 to 2014-06-30	9,445	USD	181
2007-11-16 to 2014-06-30	150,869	USD	2419
2013-04-01 to 2013-06-30	5,456	USD	91
2013-01-01 to 2013-06-30	10,262	USD	181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2007-11-16 to 2014-06-30	50,000	USD	2419

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2014-01-01 to 2014-06-30	7,805	USD	181
2007-11-16 to 2014-06-30	8,155	USD	2419
2013-01-01 to 2013-06-30	-1,675	USD	181

Inspect the source

Entity: WHITEHAWK THERAPEUTICS, INC. / CIK 0001422142
Captured: 2026-09-20T08:03:20.803Z
SEC response SHA-256: 0bc3518b433577b57088b38c087953d494e28bdd319b1da3b435ea8e7e18b0c1

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001422142.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))